HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Removal of cardiac AL amyloid with positive remodelling of cardiomyocytes and of restrictive cardiomyopathy.

Abstract
Herein, we describe histological mobilization of light chain cardiac amyloid documented by sequential left ventricular endomyocardial biopsies. These findings were associated with positive remodelling of cardiomyocytes and of restrictive cardiomyopathy resulting from 14 courses of chemotherapy over 17 years of time. Histological and ultrastructural findings of light chain cardiac amyloid removal led to increase in cardiomyocyte dimension and electrocardiogram voltages, reduction of biventricular wall thickness with improvement of left ventricular diastolic function, and NYHA class shifting from III to I.
AuthorsAndrea Frustaci, Romina Verardo, Nicola Galea, Maria Alfarano, Luigi Sansone, Matteo Antonio Russo, Cristina Chimenti
JournalESC heart failure (ESC Heart Fail) Vol. 9 Issue 6 Pg. 4330-4334 (12 2022) ISSN: 2055-5822 [Electronic] England
PMID36056647 (Publication Type: Case Reports, Research Support, Non-U.S. Gov't)
Copyright© 2022 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.
Chemical References
  • Amyloid
Topics
  • Humans
  • Cardiomyopathy, Restrictive (diagnosis, metabolism)
  • Myocytes, Cardiac (metabolism)
  • Myocardium (pathology)
  • Amyloid (metabolism)
  • Biopsy

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: